Article Text

Download PDFPDF
Expression of βV-Tubulin in Secretory Cells of the Fallopian Tube Epithelium Marks Cellular Atypia
  1. Deepti Mathew, MS*,
  2. Yanhua Wang, MD,
  3. Anne Van Arsdale, MD§,
  4. Susan Band Horwitz, PhD* and
  5. Hayley McDaid, PhD*,
  1. *Departments of Molecular Pharmacology and
  2. Medicine, Albert Einstein College of Medicine; and
  3. Departments of Pathology and
  4. §Obstetrics and Gynecology and Women's Health, Montefiore Medical Center, Bronx, NY.
  1. Address correspondence and reprint requests to Hayley McDaid, PhD, 1300 Morris Park Ave, F249b, Bronx, NY 10461. E-mail: hayley.mcdaid@einstein.yu.edu.

Abstract

Objectives Class V Beta tubulin isotype (βV-tubulin) was recently found to have tissue-specific expression patterns in epithelial tissues with secretory function and aberrant expression in tumors. The aims of this pilot study were (a) to examine expression of βV-tubulin in the fallopian tube epithelium (FTE) of patients who underwent salpingectomy, (b) to characterize FTE atypia in high-risk patients with BRCA mutations, and (c) to determine expression of βV-tubulin in serous ovarian neoplasms.

Methods Immunohistochemistry, with a highly specific antibody developed in our laboratory against human βV-tubulin, was used to evaluate expression in paraffin-embedded sections of the fallopian tube (n = 82) and tumors (n = 13), from prospectively selected cases, categorized by reason for salpingectomy.

Results βV-tubulin, when present, was expressed in secretory cells and essentially never in ciliated cells of the FTE. Histologically “normal” FTE had very rare, scattered βV-tubulin–positive cells; percentage positivity increased in cases of serous ovarian neoplasms. The highest expression was observed in FTE from patients with BRCA mutant breast cancer. Four distinct types of FTE atypia were delineated in patients with known BRCA mutations. In a few additional test cases of ovarian neoplasms, βV-tubulin was highly expressed, with the extent and intensity of staining elevated in high-grade serous carcinomas compared with serous borderline tumors.

Conclusions In summary, βV-tubulin was localized to secretory cells of the distal FTE and its expression varied according to the clinical diagnosis. The frequency of these cells and thus expression of βV-tubulin were dramatically enriched in tissue obtained from BRCA mutant cases, which also exhibited pronounced histologic atypia indicative of early predysplastic aberrations. Furthermore, elevated expression of βV-tubulin correlated with poor differentiation status in serous ovarian neoplasms.

  • β-Tubulin
  • Fallopian tube
  • Secretion
  • BRCA
  • Preneoplastic condition
  • Ovarian cancer

Statistics from Altmetric.com

Footnotes

  • Sources of support: These studies were supported by the Breast Cancer Research Foundation, the National Foundation for Cancer Research, National Cancer Institute Grant CA077263, and the Albert Einstein Cancer Center Support Grant of the National Institutes of Health, under award number P30CA013330.

  • The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

  • The authors declare no conflicts of interests.

  • Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.ijgc.net).

  • This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.